drugset / Trial / NCT01714648

Can GnRH Agonist Trigger Prevent Ovarian Hyperstimulation Syndrome?

NCT01714648

Phase 4 Terminated 6 enrolled Elisha Hospital Merck Sharp & Dohme LLC · collab
NaSingle-groupOpen-labelPrevention

Summary

Ovarian hyperstimulation syndrome (OHSS) is a major complication of ovarian stimulation for IVF if hCG is used to trigger final oocyte maturation. The investigators propose that using GnRH agonist as a trigger will eliminate OHSS, even in high-risk patients.

Timeline

Start
2012-11
Primary completion
2014-01
Completion
2014-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Triptorelin Other / unclassified 0.2 mg